Icure Pharmaceutical Incorporation

175250 · KOSDAQ · Materials · SMALL CAP

A share pledge released.

A previously disclosed share pledge on Icure Pharmaceutical Incorporation's largest shareholder (최영권) was released or cancelled, freeing collateral of $8M (₩12B).

Ownership change(최대주주변경을수반하는주식담보제공계약해제ㆍ취소등)· FILED 2026-09-01· RCEPT 20260901900199

$8MCollateral released₩12B

What happened

A previously disclosed share pledge on Icure Pharmaceutical Incorporation's largest shareholder (최영권) was released or cancelled, freeing collateral of $8M (₩12B).

Releasing the pledge removes the prospect that enforcement could have shifted the largest shareholder's stake.

Largest shareholder최영권
Collateral released$8M (₩12B)
Filed2026-09-01, 최대주주변경을수반하는주식담보제공계약해제ㆍ취소등
SourceDART rcept 20260901900199 → open original filing

Source: DART. Information only, not investment advice.

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-09-01 (KST).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.